» Articles » PMID: 28532040

Design, Synthesis and Characterization of Poly (methacrylic Acid-niclosamide) and Its Effect on Arterial Function

Overview
Publisher Elsevier
Date 2017 May 24
PMID 28532040
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We have found that niclosamide induced relaxation of constricted artery. However, niclosamide is insoluble, the low bioavailability and the resultant low plasma concentration limit its potential exertion in vivo. The aim of the present study is to synthesize a soluble poly (methacrylic acid-niclosamide) polymer (PMAN) and study the effects of PMAN on arterial function in vitro and the blood pressure and heart rate of rats in vivo. We synthesized the poly (methacrylic acid-niclosamide) polymer (PMAN), the chemical structure of which was identified by FTIR and H NMR spectra. The average molecular weight and polydispersity index of PMAN were 5138 and 1.193 respectively. Compared with niclosamide, the water solubility of niclosamide in PMAN was significantly increased. PMAN showed dose-dependent vasorelaxation effect on rat mesenteric arteries with intact or denuded endothelium in phenylephrine (PE) and high K (KPSS)-induced vasoconstriction models in vitro. The efficacy of vasorelaxant effect and the cytotoxic effect of PMAN on vascular smooth muscle cells (A10) were lower than that of niclosamide. The LD of PMAN in mice (iv) was 80mg/kg. Venous injection of PMAN (equivalent 5mg niclosamide per kg) showed acute reduction of the rat blood pressure and heart rate in vivo. In conclusion, the solubility of niclosamide was increased in the way of poly (methacrylic acid-niclosamide) polymer, which relaxes the constricted arteries in vitro and reduces the rat blood pressure and heart rate in vivo, indicating that modifying niclosamide solubility through polymerization is a feasible approach to improve its pharmacokinetic profiles for potential clinic application.

Citing Articles

Release of nifedipine, furosemide, and niclosamide drugs from the biocompatible poly(HEMA) hydrogel structures.

Yilmaz B Turk J Chem. 2023; 46(5):1710-1722.

PMID: 37529747 PMC: 10390117. DOI: 10.55730/1300-0527.3474.


Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.

Mokgautsi N, Kuo Y, Huang Y, Chen C, Mukhopadhyay D, Wu A Cells. 2023; 12(2).

PMID: 36672201 PMC: 9856425. DOI: 10.3390/cells12020266.


Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases.

Wang Z, Ren J, Du J, Wang H, Liu J, Wang G Int J Mol Sci. 2022; 23(24).

PMID: 36555754 PMC: 9782559. DOI: 10.3390/ijms232416116.


Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of /// in Cancer Types.

Mokgautsi N, Wang Y, Lawal B, Khedkar H, Sumitra M, Wu A Cancers (Basel). 2021; 13(11).

PMID: 34063946 PMC: 8196568. DOI: 10.3390/cancers13112523.


An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential /// Suppressor with Anti-Glioblastoma Properties.

Mokgautsi N, Wen Y, Lawal B, Khedkar H, Sumitra M, Wu A Int J Mol Sci. 2021; 22(5).

PMID: 33671112 PMC: 7957701. DOI: 10.3390/ijms22052464.